Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells

International Journal of Cancer

Volumn 104, Issue 6, 2003, Pages 699-708

  Schlingemann, Joerg ^a   Hess, Jochen ^a   Wrobel, Gunnar ^a   Breitenbach, Ute ^a   Gebhardt, Christoffer ^a   Steinlein, Peter ^b   Kramer, Heidi ^a   Fürstenberger, Gerhard ^a   Hahn, Meinhard ^a   Angel, Peter ^a   Lichter, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

Expression profiling; Microarray; Skin carcinogenesis; SSH; Tumour promoter

Indexed keywords

CARCINOGEN; DNA FRAGMENT; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DNA DETERMINATION; DNA LIBRARY; DNA MICROARRAY; DOWN REGULATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA HYBRIDIZATION; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; UNINDEXED SEQUENCE;

ANIMALS; BLOTTING, NORTHERN; CARCINOGENS; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; IN SITU HYBRIDIZATION; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SKIN; SKIN NEOPLASMS; SUBTRACTION TECHNIQUE; TETRADECANOYLPHORBOL ACETATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0345701256     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11008     Document Type: Article

References (77)

1. Yuspa, SH. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res 1994;54:1178-89.
2. Marks F, Furstenberger G. The conversion stage of skin carcinogenesis. Carcinogenesis 1990;11:2085-92.
3. Velculescu VE, Zhang L, Vogelstein B, Kinzler, KW. Serial analysis of gene expression. Science 1995;270:484-87.
4. Brenner S, Johnson M, Bridgham J, Golda G, Lloyd DH, Johnson D, Luo S, McCurdy S, Foy M, Ewan M, Roth R, George D, et al. Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol 2000;18:630-34.
5. Sutcliffe JG, Foye PE, Erlander MG, Hilbush BS, Bodzin LJ, Durham JT, Hasel, KW. TOGA: an automated parsing technology for analyzing expression of nearly all genes. Proc Natl Acad Sci USA 2000;97:1976-81.
6. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675-80.
7. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70.
8. Yokota J. Tumor progression and metastasis. Carcinogenesis 2000;21:497-503.
9. Breitenbach U, Tuckermann JP, Gebhardt C, Richter KH, Furstenberger G, Christofori G, Angel P. Keratinocyte-specific onset of serine protease BSSP expression in experimental carcinogenesis. J Invest Dermatol 2001;117:634-640.
10. Yang GP, Ross DT, Kuang WW, Brown PO, Weigel RJ. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res 1999;27:1517-23.
11. Beitner-Johnson D, Seta K, Yuan Y, Kim H, Rust RT, Conrad PW, Kobayashi S, Millhorn DE. Identification of hypoxia-responsive genes in a dopaminergic cell line by subtractive cDNA libraries and microarray analysis. Parkinsonism Relat Disord 2001;7:273-81.
12. Seta KA, Kim R, Kim HW, Millhorn DE, Beitner-Johnson D. Hypoxia-induced regulation of MAPK phosphatase-I as identified by subtractive suppression hybridization and cDNA microarray analysis. J Biol Chem 2001:276:44405-12.
13. Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ, Serrano M. Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene 1995;11:635-45.
14. Strickland JE, Greenhalgh DA, Koceva-Chyla A, Hennings H, Restrepo C, Balaschak M, Yuspa SH. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 1988;48:165-9.
15. Buchmann A, Ruggeri B, Klein-Szanto AJ, Balmain A. Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res 1991;51:4097-4101.
16. Furstenberger G, Kopp-Schneider A Malignant progression of papillomas induced by the initiation - promotion protocol in NMRI mouse skin. Carcinogenesis 1995;16:61-9.
17. Fritz B, Schubert F, Wrobel G, Schwaenen C, Wessendorf S, Nessling M, Korz C, Rieker R, Kucherlapati R, Mechtersheimer G, Eils R, et al. Microarray based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res 2002;62:2993-8.
18. DeRisi JL, Iyer VR, Brown PO. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 1997;278:680-6.
19. DeRisi JL, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996;14:457-60.
20. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 1996;93:10614-19.
21. Ihaka R, Gentleman RR. A language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
22. Korz C, Pscherer A, Benner A, Mertens D, Schaffner C, Leupolt E, Dohner H, Stilgenbauer S, Lichter P. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 2002;99:4551-61.
23. Gack S, Vallon R, Schmidt J, Grigoriadis A, Tuckermann J, Schenkel J, Weiher H, Wagner EF, Angel P. Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Diff 1995;6:759-767.
24. Gebhardt C, Breitenbach U, Tuckermann JP, Dittrich BT, Richter KH, Angel P. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene 2002;21:4266-76.
25. Ito N, Hasegawa R, Imaida K, Hirose M, Asamoto M, Shirai T. Concepts in multistage carcinogenesis. Crit Rev Oncol Hematol 1995;21:105-33.
26. Marshall E. Genome sequencing. Public group completes draft of the mouse. Science 2002;296:1005.
27. Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002;21:2634-40.
28. Seo J, Kim M, Kim J. Identification of novel genes differentially expressed in PMA-induced HL-60 cells using cDNA microarrays. Mol Cells 2000;10:733-9.
29. Hofmann WK, de Vos S, Tsukasaki K, Wachsman W, Pinkus GS, Said JW and Koeffler HP. Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood 2001;98:787-94.
30. Marks F, Furstenberger G. The conversion stage of skin carcinogenesis. Carcinogenesis 1990;11:2085-92.
31. Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J 1998;332:281-92.
32. Rahmsdorf HJ, Herrlich P. Regulation of gene expression by tumor promoters. Pharmacol Ther 1990;48:157-88.
33. van Ruissen F, Jansen BJ, de Jongh GJ, van Vlijmen-Willems IM, Schalkwijk J. Differential gene expression in premalignant human epidermis revealed by cluster analysis of serial analysis of gene expression (SAGE) libraries. FASEB J 2002;16:246-8.
34. Sark MW, Fischer DF, de Meijer E, van de Putte P, Backendorf C. AP-1 and ets transcription factors regulate the expression of the human SPRRIA keratinocyte terminal differentiation marker. J Biol Chem 1998;273:24683-92.
35. Maruyama M, Hay JG, Yoshimura K, Chu CS, Crystal RG. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester. J Clin Invest 1994;94:368-75.
36. Sallenave JM, Si-Ta har M, Cox G, Chignard M, Gauldie J. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J Leukoc Biol 1997;61:695-702.
37. White MA, Vale T, Camonis JH, Schaefer E, Wigler MH. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J Biol Chem 1996;271:16439-42.
38. Ushmorov AG, Furstenberger G, Faissner A, Marks F. Effects of complete and incomplete tumor promoters on hair growth, angiogenesis, and tenascin expression in the skin of NMRI mice. Carcinogenesis 1994;15:2739-45.
39. Vollmer G, Tan MI, Wunsche W, Frank K. Expression of tenascin-C by human endometrial adenocarcinoma and stroma cells: heterogeneity of splice variants and induction by TGF-beta. Biochem Cell Biol 1997;75:759-69.
40. Inase N, Fushimi K, Ishibashi K, Uchida S, Ichioka M, Sasaki S, Marumo F. Isolation of human aquaporin 3 gene. J Biol Chem 1995;270:17913-16.
41. Pellerin S, Croizet K, Rabilloud R, Feige JJ, Rousset B. Regulation of the three-dimensional organization of thyroid epithelial cells into follicle structures by the matricellular protein, thrombospondin-1. Endocrinology 1999;140:1094-1103.
42. Sargiannidou I, Zhou J, Tuszynski GP. The role of thrombospondin-1 in tumor progression. Exp Biol Med (Maywood) 2001;226:726-33.
43. Fall PM, Breault DT, Raisz LG. Inhibition of collagen synthesis by prostaglandins in the immortalized rat osteoblastic cell line Py1a: structure-activity relations and signal transduction mechanisms. J Bone Miner Res 1994;9:1935-43.
44. La Celle PT, Polakowska RR. Human homeobox HOXA7 regulates keratinocyte transglutaminase type 1 and inhibits differentiation. J Biol Chem 2001;276:32844-53.
45. Michelson RJ, Collard MW, Ziemba AJ, Persinger J, Bartholomew B, Huggenvik JI. Nuclear DEAF-1-related (NUDR) protein contains a novel DNA binding domain and represses transcription of the heterogeneous nuclear ribonucleoprotein A2/B1 promoter. J Biol Chem 1999;274:30510-9.
46. Mason IJ, Murphy D, Munke M, Francke U, Elliott RW, Hogan BL. Developmental and transformation-sensitive expression of the Sparc gene on mouse chromosome 11. EMBO J 1986;5:1831-7.
47. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-57.
48. Angel P, Szabowski A, Schorpp-Kistner M. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 2001;20:2413-23.
49. Hsu TC, Young MR, Cmarik J, Colburn NH. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med 2000;28:1338-48.
50. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999;98:137-46.
51. Tuckermann JP, Reichardt HM, Arribas R, Richter KH, Schutz G, Angel P. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J Cell Biol 1999;147:1365-70.
52. van Dam H, Castellazzi M. Distinct roles of Jun:Fos and Jun: ATF dimers in oncogenesis. Oncogene 2001;20:53-2464.
53. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 1987;49:729-39.
54. Angel P, Poting A, Mallick U, Rahmsdorf HJ, Schorpp M, Herrlich P. Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts. Mol Cell Biol 1986;6:1760-6.
55. An G, Tesfaigzi J, Chuu YJ, Wu R. Isolation and characterization of the human spr1 gene and its regulation of expression by phorbol ester and cyclic AMP. J Biol Chem 1993;268:10977-82.
56. Rutberg SE, Saez E, Glick A, Dlugosz AA, Spiegelman BM, Yuspa SH. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. Oncogene 1996;13:167-76.
57. Nacken W, Lekstrom-Himes JA, Sorg C, Manitz MP. Molecular analysis of the mouse S100A9 gene and evidence that the myeloid specific transcription factor C/EBPepsilon is not required for the regulation of the S100A9/A8 gene expression in neutrophils. J Cell Biochem 2001;80:606-16.
58. Nacken W, Manitz MP, Sorg C. Molecular characterisation of the genomic locus of the mouse MRP8 gene. Biochim Biophys Acta 1996;1315:1-5.
59. Kikuchi T, Abe T, Hoshi S, Matsubara N, Tominaga Y, Satoh K, Nukiwa T. Structure of the murine secretory leukoprotease inhibitor (Slpi) gene and chromosomal localization of the human and murine SLPI genes. Am J Respir Cell Mol Biol 1998;19:875-80.
60. Chang A, Ramsay P, Zhao B, Park M, Magdaleno S, Reardon MJ, Welty S, DeMayo FJ. Physiological regulation of uteroglobin/CCSP expression. Ann NY Acad Sci 2000;923:181-92.
61. Budunova IV, Perez P, Vaden VR, Spiegelman VS, Slaga TJ, Jorcano JL. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Oncogene 1999;18:7423-31.
62. Boelsma E, Gibbs S, Ponec M. Expression of skin-derived antileukoproteinase (SKALP) in reconstructed human epidermis and its value as a marker for skin irritation. Acta Derm Venereol 1998;78:107-13.
63. Thorey IS, Roth J, Regenbogen J, Halle JP, Bittner M, Vogl T, Kaesler S, Bugnon P, Reitmaier B, Durka S, Graf A, Wockner M, et al. The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem 2001;276:35818-25.
64. McGaha T, Saito S, Phelps RG, Gordon R, Noben-Trauth N, Paul WE and Bona C. Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes. J Invest Dermatol 2001;116:136-43.
65. LaDuca JR, Gaspari AA. Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases. Dermatol Clin 2001;19:617-35.
66. Bradshaw AD, Reed MJ, Sage EH. SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cytochem 2002;50:1-10.
67. Wang H, Liao WS. Functional analysis of a minimal mouse serum amyloid A3 promoter in transgenic mice. Amyloid 2001;8:250-56.
68. Marks F, Furstenberger G, Heinzelmann T, Muller-Decker K. Mechanisms in tumor promotion: guidance for risk assessment and cancer chemoprevention. Toxicol Lett 1995;82-83:907-17.
69. Furstenberger G, Rogers M, Schnapke R, Bauer G, Hofler P, Marks F. Stimulatory role of transforming growth factors in multistage skin carcinogenesis: possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skin. Int J Cancer 1989;43:915-21.
70. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
71. Krieg P, Feil S, Furstenberger G, Bowden GT. Tumor-specific over-expression of a novel keratinocyte lipid-binding protein. Identification and characterization of a cloned sequence activated during multistage carcinogenesis in mouse skin. J Biol Chem 1993;268:17362-9.
72. Matrisian LM, Bowden GT, Krieg P, Furstenberger G, Briand JP, Leroy P, Breathnach R. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci USA 1986;83:9413-7.
73. Matrisian LM, Leroy P, Ruhlmann C, Gesnel MC, Breathnach R. Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol Cell Biol 1986;6:1679-86.
74. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000;103:481-90.
75. Bergers G, Coussens LM. Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev 2000;10:120-7.
76. Herrlich P, Pals S, Ponta H. CD44 in colon cancer. Eur J Cancer 1995;31A:1110-2.
77. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1999;13:35-48.